Clinical Trials Browser

Interventional × Breast Neoplasms × tusamitamab ravtansine × Clear all

NCT05703555 2024-02-28

INTRUSION

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms